🇺🇸 FDA
Patent

US 11744828

Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

granted A61KA61K31/4706A61P

Quick answer

US patent 11744828 (Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects) held by The Government of the United States, as represented by the Secretary of the Army expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States, as represented by the Secretary of the Army
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4706, A61P, A61P33/06